March 29, 2013- Techfidera pills and capsules have received approval from the United States Food and Drug Administration (FDA) as a way to treat relapsing forms of multiple sclerosis (MS).
This new drug is the third oral application for multiple sclerosis treatment approved by the federal agency.
Multiple Sclerosis is a terrible affliction, an autoimmune disease which mistakenly attacks and damages protective coverings around nerve cells in the human body.
The disease affects the signals between the brain and the body and slows or even stops them from occurring.
Most people who suffer from multiple sclerosis have relapses which are generally followed by periods of remission. Techfidera can help limit those times when relapses occur.
The symptoms of multiple sclerosis are muscle weakness and problems with coordination and balance. The drug, according to the FDA, can go a long way to ward eliminating those symptoms.
Biogen Idec, a pharmaceutical manufacturer located in Parsippany, New Jersey is the producer of Techfidera. The company is hopeful that its new product will live up to its promise, help sufferers of multiple sclerosis and produce significant revenues, as well.
Time will tell if all of that actually takes place. And that time begins now.